Wegovy and Ozempic Will Cost Less in 2027. Here Are the New Slashed Prices

The price of the popular GLP-1 medications will be cut, starting in January of 2027, manufacturer Novo Nordisk said in a ...

Eli Lilly's weight-loss pill shows higher side effects than Novo rival in diabetes trial

Feb 26 (Reuters) - Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment ...

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or ...
BioPharma Dive

Lilly’s GLP-1 pill tops Novo’s Rybelsus in head-to-head trial

Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but at the expense of higher side effect rates.

Lilly’s New Weight‑Loss Pill Shows Double the Results of Novo Nordisk’s GLP-1 Rival in a Major Study

Lilly’s new data show its oral GLP-1 beating Novo’s on major benchmarks.

Novo Nordisk slashing prices for weight-loss and diabetes drugs Ozempic, Wegovy and Rybelsus

Novo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and ...

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.
Yahoo

What Endocrinologists Want You to Know About Rybelsus and Ozempic

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Interest surrounding glucagon-like peptide 1 agonists (GLP-1), a class of type 2 diabetes drugs that help ...

Popular weight-loss drugs getting cheaper amid price war

Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.